Your SlideShare is downloading. ×
0
Evangeline Chee
Evangeline Chee
Evangeline Chee
Evangeline Chee
Evangeline Chee
Evangeline Chee
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Evangeline Chee

153

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
153
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. China AND INDIA MAKING INROADS IN BIOTECH DRUGS<br />New York Times, 18 September 2011<br />
  • 2. Definitions<br />Brand-name drug = a drug that has a trade name and is protected by a patent<br />Patent = exclusive rights to produce and sell a product<br />Generic drug = cheaper but equally effective version of brand-name drug; manufactured without a licence and after the patent has expired<br />
  • 3. Interesting points<br />How developing countries attempt to circumvent patents<br />How the pharmaceutical industry and richer nations are fighting back<br />Similarities between the current dilemma over cancer drugs and the one over AIDS 10 years ago<br />
  • 4. Key takeaways<br />China and India can now copy the biotech drugs used to treat cancer, diabetes and other non-communicable diseases<br />Effect<br />Pharmaceutical companies and richer countries vs developing countries<br />Reduce healthcare costs<br />
  • 5. Why I chose this topic<br />Has a legal element<br />Reflects the need to weigh competing policy considerations<br />Rating: 8/10<br />
  • 6. Discussion questions<br />Who will win the battle? Will developing countries be able to get the pharmaceutical industry to give up their patent rights for cancer drugs (and the accompanying profits)?<br />Who should win the battle?<br />

×